| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.68 | 0.01 |